|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||||
| Investments at fair value | ||||||||||||||
| Non-Control / Non-Affiliate investments | ||||||||||||||
| Affiliate investments | ||||||||||||||
| Control investments | ||||||||||||||
| Short-term investments | ||||||||||||||
| Total control investments | ||||||||||||||
| Total investments at fair value | ||||||||||||||
| Cash (restricted cash of $27,633 and $11,146 as of June 30, 2026 and December 31, 2025, respectively) | ||||||||||||||
| Foreign currencies (cost of $23,938 and $23,717 as of June 30, 2026 and December 31, 2025, respectively) | ||||||||||||||
| Interest and fees receivable | ||||||||||||||
| Investments funded in advance | ||||||||||||||
| Prepaid expenses and other assets | ||||||||||||||
| Derivative assets | ||||||||||||||
| Deferred financing fees | ||||||||||||||
| Receivable from unsettled transactions | ||||||||||||||
| Total assets | ||||||||||||||
| Liabilities: | ||||||||||||||
| Accounts payable and accrued liabilities | ||||||||||||||
| Share repurchases payable | ||||||||||||||
| Interest payable | ||||||||||||||
| Administrative fees payable | ||||||||||||||
| Base management fees payable | ||||||||||||||
| Incentive management fees payable | ||||||||||||||
| Derivative liabilities | ||||||||||||||
| Payable from unsettled transactions | ||||||||||||||
| Borrowings under credit facilities | ||||||||||||||
| Debt securitization (net of deferred financing fees) | ||||||||||||||
| Notes payable (net of deferred financing fees) | ||||||||||||||
| Secured borrowings | ||||||||||||||
| Total liabilities | ||||||||||||||
| Net Assets: | ||||||||||||||
| Common stock, $0.001 par value per share (499,950,000 shares authorized, 141,610,315 and 139,486,706 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively) | ||||||||||||||
| Additional paid-in capital | ||||||||||||||
| Total distributable earnings | ||||||||||||||
| Total net assets | ||||||||||||||
| Total liabilities and net assets | ||||||||||||||
| Net asset value per share (in dollars per share) |
Loading...
